Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6167587rdf:typepubmed:Citationlld:pubmed
pubmed-article:6167587lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:6167587lifeskim:mentionsumls-concept:C0021747lld:lifeskim
pubmed-article:6167587lifeskim:mentionsumls-concept:C0023689lld:lifeskim
pubmed-article:6167587lifeskim:mentionsumls-concept:C0035693lld:lifeskim
pubmed-article:6167587lifeskim:mentionsumls-concept:C0204727lld:lifeskim
pubmed-article:6167587lifeskim:mentionsumls-concept:C0205409lld:lifeskim
pubmed-article:6167587lifeskim:mentionsumls-concept:C1257756lld:lifeskim
pubmed-article:6167587lifeskim:mentionsumls-concept:C1881065lld:lifeskim
pubmed-article:6167587lifeskim:mentionsumls-concept:C1880022lld:lifeskim
pubmed-article:6167587pubmed:issue17lld:pubmed
pubmed-article:6167587pubmed:dateCreated1981-10-29lld:pubmed
pubmed-article:6167587pubmed:abstractText(2'-5')(A)n synthetase is one of the mediators of interferon action. If activated by double-stranded RNA it converts ATP into pyrophosphate and (2'-5')(A)n. In turn, (2'-5')(A)n activates a latent endoribonuclease (RNase L) which cleaves single-stranded RNA. We report here the isolation and characterization of a homogeneous human (2'-5')(A)n synthetase. The enzyme was purified from interferon-treated HeLA S3 cells by chromatography of a ribosomal salt wash fraction on DEAE-cellulose, poly(I) . poly(C) agarose, and CM-cellulose. The purified (2'-5')(A)n synthetase can convert over 90% of ATP into (2'-5')(A)n. The enzyme is unstable but can be stabilized by certain nonionic detergents (e.g. Triton X-100). Its apparent Mr = 100,000, as determined by gel electrophoresis in sodium dodecyl sulfate, and about 80,000, as determined by centrifugation through a glycerol gradient. The human (2'-5')(A)n synthetase is similar to the corresponding enzyme from mouse Ehrlich ascites tumor cells, but differs from the latter in size (100,000 versus 105,000 daltons) and in ionic conditions required for maximal activity.lld:pubmed
pubmed-article:6167587pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6167587pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6167587pubmed:languageenglld:pubmed
pubmed-article:6167587pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6167587pubmed:citationSubsetIMlld:pubmed
pubmed-article:6167587pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6167587pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6167587pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6167587pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6167587pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6167587pubmed:statusMEDLINElld:pubmed
pubmed-article:6167587pubmed:monthSeplld:pubmed
pubmed-article:6167587pubmed:issn0021-9258lld:pubmed
pubmed-article:6167587pubmed:authorpubmed-author:LengyelPPlld:pubmed
pubmed-article:6167587pubmed:authorpubmed-author:SamantaHHlld:pubmed
pubmed-article:6167587pubmed:authorpubmed-author:DoughertyJJlld:pubmed
pubmed-article:6167587pubmed:authorpubmed-author:JayaramBBlld:pubmed
pubmed-article:6167587pubmed:authorpubmed-author:YanoCClld:pubmed
pubmed-article:6167587pubmed:authorpubmed-author:BroezeRRlld:pubmed
pubmed-article:6167587pubmed:issnTypePrintlld:pubmed
pubmed-article:6167587pubmed:day10lld:pubmed
pubmed-article:6167587pubmed:volume256lld:pubmed
pubmed-article:6167587pubmed:ownerNLMlld:pubmed
pubmed-article:6167587pubmed:authorsCompleteYlld:pubmed
pubmed-article:6167587pubmed:pagination9324-8lld:pubmed
pubmed-article:6167587pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:6167587pubmed:meshHeadingpubmed-meshheading:6167587-...lld:pubmed
pubmed-article:6167587pubmed:meshHeadingpubmed-meshheading:6167587-...lld:pubmed
pubmed-article:6167587pubmed:meshHeadingpubmed-meshheading:6167587-...lld:pubmed
pubmed-article:6167587pubmed:meshHeadingpubmed-meshheading:6167587-...lld:pubmed
pubmed-article:6167587pubmed:meshHeadingpubmed-meshheading:6167587-...lld:pubmed
pubmed-article:6167587pubmed:meshHeadingpubmed-meshheading:6167587-...lld:pubmed
pubmed-article:6167587pubmed:meshHeadingpubmed-meshheading:6167587-...lld:pubmed
pubmed-article:6167587pubmed:meshHeadingpubmed-meshheading:6167587-...lld:pubmed
pubmed-article:6167587pubmed:meshHeadingpubmed-meshheading:6167587-...lld:pubmed
pubmed-article:6167587pubmed:meshHeadingpubmed-meshheading:6167587-...lld:pubmed
pubmed-article:6167587pubmed:meshHeadingpubmed-meshheading:6167587-...lld:pubmed
pubmed-article:6167587pubmed:year1981lld:pubmed
pubmed-article:6167587pubmed:articleTitleInterferons, double-stranded RNA, and RNA degradation. Isolation and characterization of homogeneous human (2'-5')(a)n synthetase.lld:pubmed
pubmed-article:6167587pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:6167587pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6167587lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6167587lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6167587lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6167587lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6167587lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6167587lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6167587lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6167587lld:pubmed